What are the treatment options for Wolff-Parkinson-White (WPW) syndrome?

Updated: Jan 08, 2017
  • Author: Christopher R Ellis, MD, FACC, FHRS; Chief Editor: Mikhael F El-Chami, MD  more...
  • Print

Treatment of Wolff-Parkinson-White (WPW)-associated arrhythmias is directed at the underlying cause (through the use of radiofrequency [RF] ablation of the accessory pathway [AP], antiarrhythmic drugs in adults to slow AP conduction in certain situations (ie, Mahaim or atriofascicular pathway-mediated supraventricular tachycardia [SVT]; typically, atrioventricular [AV] nodal-conduction blocking medications are avoided in the acute setting of WPW), or AV nodal blocking medications to slow AV nodal conduction).

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!